nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation of mitochondrial fusion provides a new treatment for mitochondria-related diseases
|
Szabo, Aliz |
|
2018 |
150 |
C |
p. 86-96 |
artikel |
2 |
A fungal metabolite zearalenone as a CFTR inhibitor and potential therapy of secretory diarrheas
|
Muangnil, Paradorn |
|
2018 |
150 |
C |
p. 293-304 |
artikel |
3 |
Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction
|
Sonowal, Himangshu |
|
2018 |
150 |
C |
p. 181-190 |
artikel |
4 |
Anti-inflammatory actions of Caesalpinin M2 in experimental colitis as a selective glucocoricoid receptor modulator
|
Xiang, Gang |
|
2018 |
150 |
C |
p. 150-159 |
artikel |
5 |
Atorvastatin impaired glucose metabolism in C2C12 cells partly via inhibiting cholesterol-dependent glucose transporter 4 translocation
|
Sun, Binbin |
|
2018 |
150 |
C |
p. 108-119 |
artikel |
6 |
Baicalein and baicalin alleviate acetaminophen-induced liver injury by activating Nrf2 antioxidative pathway: The involvement of ERK1/2 and PKC
|
Shi, Liang |
|
2018 |
150 |
C |
p. 9-23 |
artikel |
7 |
BMP-2 induces angiogenesis by provoking integrin α6 expression in human endothelial progenitor cells
|
Chen, Wei-Cheng |
|
2018 |
150 |
C |
p. 256-266 |
artikel |
8 |
Delineation of the functional properties and the mechanism of action of AA29504, an allosteric agonist and positive allosteric modulator of GABAA receptors
|
Olander, Emma Rie |
|
2018 |
150 |
C |
p. 305-319 |
artikel |
9 |
Dihydroartemisinin suppresses STAT3 signaling and Mcl-1 and Survivin expression to potentiate ABT-263-induced apoptosis in Non-small Cell Lung Cancer cells harboring EGFR or RAS mutation
|
Yan, Xiaohui |
|
2018 |
150 |
C |
p. 72-85 |
artikel |
10 |
Editorial Board
|
|
|
2018 |
150 |
C |
p. ii |
artikel |
11 |
Efflux inhibition by IWR-1-endo confers sensitivity to doxorubicin effects in osteosarcoma cells
|
Gustafson, Carl T. |
|
2018 |
150 |
C |
p. 141-149 |
artikel |
12 |
Extracellular loops 2 and 3 of the calcitonin receptor selectively modify agonist binding and efficacy
|
Dal Maso, Emma |
|
2018 |
150 |
C |
p. 214-244 |
artikel |
13 |
Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R antibody fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites
|
Li, Caina |
|
2018 |
150 |
C |
p. 46-53 |
artikel |
14 |
Human GIP(3-30)NH2 inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptors
|
Gabe, Maria Buur Nordskov |
|
2018 |
150 |
C |
p. 97-107 |
artikel |
15 |
Lanatoside C inhibits cell proliferation and induces apoptosis through attenuating Wnt/β-catenin/c-Myc signaling pathway in human gastric cancer cell
|
Hu, Yudong |
|
2018 |
150 |
C |
p. 280-292 |
artikel |
16 |
Natural small molecule bigelovin suppresses orthotopic colorectal tumor growth and inhibits colorectal cancer metastasis via IL6/STAT3 pathway
|
Li, Mingyue |
|
2018 |
150 |
C |
p. 191-201 |
artikel |
17 |
PARP-1 inhibition ameliorates elastase induced lung inflammation and emphysema in mice
|
Dharwal, Vivek |
|
2018 |
150 |
C |
p. 24-34 |
artikel |
18 |
PBA2 exhibits potent anti-tumor activity via suppression of VEGFR2 mediated-cell proliferation and angiogenesis
|
Fang, Xiaona |
|
2018 |
150 |
C |
p. 131-140 |
artikel |
19 |
Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available RORγt inverse agonist
|
Shibata, Akira |
|
2018 |
150 |
C |
p. 35-45 |
artikel |
20 |
Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung
|
Gabriele, Morena |
|
2018 |
150 |
C |
p. 64-71 |
artikel |
21 |
Regulation of Kv4.3 and hERG potassium channels by KChIP2 isoforms and DPP6 and response to the dual K+ channel activator NS3623
|
Lainez, Sergio |
|
2018 |
150 |
C |
p. 120-130 |
artikel |
22 |
Regulation on SIRT1-PGC-1α/Nrf2 pathway together with selective inhibition of aldose reductase makes compound hr5F a potential agent for the treatment of diabetic complications
|
Wang, Zhihua |
|
2018 |
150 |
C |
p. 54-63 |
artikel |
23 |
Resveratrol suppresses doxorubicin-induced cardiotoxicity by disrupting E2F1 mediated autophagy inhibition and apoptosis promotion
|
Gu, Jun |
|
2018 |
150 |
C |
p. 202-213 |
artikel |
24 |
REV-ERBβ is required to maintain normal wakefulness and the wake-inducing effect of dual REV-ERB agonist SR9009
|
Amador, Ariadna |
|
2018 |
150 |
C |
p. 1-8 |
artikel |
25 |
Salmeterol, agonist of β2-aderenergic receptor, prevents systemic inflammation via inhibiting NLRP3 inflammasome
|
Song, Nanshan |
|
2018 |
150 |
C |
p. 245-255 |
artikel |
26 |
STAT3 contributes to lysosomal-mediated cell death in a novel derivative of riccardin D-treated breast cancer cells in association with TFEB
|
Li, Lin |
|
2018 |
150 |
C |
p. 267-279 |
artikel |
27 |
Stimulation of TRPV1 channels activates the AP-1 transcription factor
|
Backes, Tobias M. |
|
2018 |
150 |
C |
p. 160-169 |
artikel |
28 |
The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines
|
Senatorov, Ilya S. |
|
2018 |
150 |
C |
p. 170-180 |
artikel |